BRISTOL MYERS SQUIBB

🇫🇷France
Ownership
-
Established
1989-01-01
Employees
30K
Market Cap
$97.5B
Website
https://www.bms.com/

A Study to Assess the Effects of BMS-986371 on the Drug Levels of Methotrexate in the Presence and Absence of Sulfasalazine

First Posted Date
2022-07-06
Last Posted Date
2023-02-08
Lead Sponsor
Bristol-Myers Squibb
Target Recruit Count
30
Registration Number
NCT05445440
Locations
🇺🇸

Quotient Sciences Miami, Miami, Florida, United States

A Study of Treatment Patterns and Outcomes in Participants With Stage IIIA Melanoma Receiving Adjuvant Systemic Therapy

Completed
Conditions
First Posted Date
2022-06-27
Last Posted Date
2024-01-18
Lead Sponsor
Bristol-Myers Squibb
Target Recruit Count
95
Registration Number
NCT05432622
Locations
🇺🇸

Local Institution, The Woodlands, Texas, United States

Treatment Patterns and Outcomes in Participants With Advanced Melanoma in Germany Using a German Database

Completed
Conditions
First Posted Date
2022-06-21
Last Posted Date
2022-06-21
Lead Sponsor
Bristol-Myers Squibb
Target Recruit Count
1008
Registration Number
NCT05426239
Locations
🇩🇪

Site0001, Frankfurt, Germany

A Study to Assess 7/8 HLA-matched Hematopoietic Stem Cell Transplantation Participants Treated With or Without Abatacept in Combination With a Calcineurin Inhibitor and Methotrexate

Completed
Conditions
First Posted Date
2022-06-16
Last Posted Date
2022-06-16
Lead Sponsor
Bristol-Myers Squibb
Target Recruit Count
378
Registration Number
NCT05421299
Locations
🇺🇸

Local Institution, Princeton, New Jersey, United States

A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database

First Posted Date
2022-06-16
Last Posted Date
2022-06-16
Lead Sponsor
Bristol-Myers Squibb
Target Recruit Count
1450
Registration Number
NCT05421442
Locations
🇺🇸

Local Institution, Princeton, New Jersey, United States

A Study of Overall Survival in Participants With Metastatic Colorectal Cancer (mCRC)

First Posted Date
2022-06-15
Last Posted Date
2022-08-19
Lead Sponsor
Bristol-Myers Squibb
Target Recruit Count
124
Registration Number
NCT05420909
Locations
🇺🇸

Local Institution, Princeton, New Jersey, United States

A Study of Mavacamten in Obstructive Hypertrophic Cardiomyopathy

Phase 3
Active, not recruiting
Conditions
Interventions
First Posted Date
2022-06-10
Last Posted Date
2024-12-04
Lead Sponsor
Bristol-Myers Squibb
Target Recruit Count
38
Registration Number
NCT05414175
Locations
🇯🇵

Local Institution - 0026, Himeji-Shi, Hyogo, Japan

🇯🇵

Local Institution - 0020, Uwajima, Ehime, Japan

🇯🇵

Local Institution - 0016, Kobe-shi, Hyogo, Japan

and more 17 locations

An Efficacy and Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy in Chinese Participants With Acute Myeloid Leukemia in Complete Remission

Phase 2
Active, not recruiting
Conditions
Interventions
First Posted Date
2022-06-09
Last Posted Date
2024-10-01
Lead Sponsor
Bristol-Myers Squibb
Target Recruit Count
78
Registration Number
NCT05413018
Locations
🇨🇳

Local Institution - 0010, Shenzhen, Guangdong, China

🇨🇳

Local Institution - 0001, Tianjin, Tianjin, China

🇨🇳

Local Institution - 0007, Wenzhou City, Zhejiang, China

and more 31 locations

A Post-marketing Study to Assess the Safety of Abatacept in Sweden Using the Swedish Rheumatology Quality Register (SRQ) Register

Active, not recruiting
Conditions
First Posted Date
2022-06-09
Last Posted Date
2022-06-09
Lead Sponsor
Bristol-Myers Squibb
Target Recruit Count
4300
Registration Number
NCT05413044
Locations
🇺🇸

Local Institution, Princeton, New Jersey, United States

A Study to Evaluate the Drug Levels of BMS-986166 in Healthy Male Participants

Phase 1
Completed
Conditions
Interventions
First Posted Date
2022-06-08
Last Posted Date
2023-03-22
Lead Sponsor
Bristol-Myers Squibb
Target Recruit Count
7
Registration Number
NCT05409157
Locations
🇺🇸

Local Institution - 0001, Madison, Wisconsin, United States

© Copyright 2024. All Rights Reserved by MedPath